Cargando…
Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance
IMPORTANCE: The association of prostate-specific antigen velocity (PSAV) with clinical progression in patients with localized prostate cancer managed with active surveillance remains unclear and, to our knowledge, has not been studied in African American patients. OBJECTIVES: To test the hypothesis...
Autores principales: | Nelson, Tyler J., Javier-DesLoges, Juan, Deka, Rishi, Courtney, P. Travis, Nalawade, Vinit, Mell, Loren, Murphy, James, Parsons, J. Kellogg, Rose, Brent S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129822/ https://www.ncbi.nlm.nih.gov/pubmed/33999164 http://dx.doi.org/10.1001/jamanetworkopen.2021.9452 |
Ejemplares similares
-
Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023) -
Disparities in Telemedicine Utilization for Urology Patients During the COVID-19 Pandemic
por: Javier-DesLoges, Juan, et al.
Publicado: (2022) -
Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults
por: Kumar, Abhishek, et al.
Publicado: (2019) -
EDITORIAL COMMENT
por: Javier-DesLoges, Juan, et al.
Publicado: (2022) -
Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims
por: Moran, Ryan J, et al.
Publicado: (2019)